Correlation Between Cellectar Biosciences and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Cellectar Biosciences and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cellectar Biosciences and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cellectar Biosciences and Virax Biolabs Group, you can compare the effects of market volatilities on Cellectar Biosciences and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cellectar Biosciences with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cellectar Biosciences and Virax Biolabs.
Diversification Opportunities for Cellectar Biosciences and Virax Biolabs
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cellectar and Virax is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Cellectar Biosciences and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Cellectar Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cellectar Biosciences are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Cellectar Biosciences i.e., Cellectar Biosciences and Virax Biolabs go up and down completely randomly.
Pair Corralation between Cellectar Biosciences and Virax Biolabs
Given the investment horizon of 90 days Cellectar Biosciences is expected to under-perform the Virax Biolabs. But the stock apears to be less risky and, when comparing its historical volatility, Cellectar Biosciences is 2.52 times less risky than Virax Biolabs. The stock trades about 0.0 of its potential returns per unit of risk. The Virax Biolabs Group is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 409.00 in Virax Biolabs Group on September 12, 2024 and sell it today you would lose (228.00) from holding Virax Biolabs Group or give up 55.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cellectar Biosciences vs. Virax Biolabs Group
Performance |
| Timeline |
| Cellectar Biosciences |
| Virax Biolabs Group |
Cellectar Biosciences and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cellectar Biosciences and Virax Biolabs
The main advantage of trading using opposite Cellectar Biosciences and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cellectar Biosciences position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Cellectar Biosciences vs. Monopar Therapeutics | Cellectar Biosciences vs. Pulmatrix | Cellectar Biosciences vs. Tenax Therapeutics | Cellectar Biosciences vs. Bio Path Holdings |
| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stocks Directory Find actively traded stocks across global markets |